Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5509558 | Clinica Chimica Acta | 2017 | 6 Pages |
Abstract
This meta-analysis showed that increased expression of HOXA11-AS is a risk factor for poor clinical outcomes in numerous tumors and may act as a novel biomarker for poor prognosis and metastasis in cancers.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Na Li, Meilan Yang, Ke Shi, Wei Li,